Anti-Cancer CAS 122111-03-9 Gemcitabine HCl API Gemcitabine Hydrochloride Raw Material Gemcitabine

Min.Order: 1
Product origin: Xi'an, Shaanxi, China
Infringement complaint: complaintComplaint
US$ 20 ~ 30

Description
Anti-Cancer CAS 122111-03-9 Gemcitabine HCL API Gemcitabine Hydrochloride Raw Material Gemcitabine
Product Description
Product Details
Product nameGemcitabine Hydrochloride
AppearanceWhite powder
CAS NO.122111-03-9
MFC9H12ClF2N3O4
MW263.198146
Gemcitabine hydrochloride is a synthetic novel difluoro nucleoside drug that is anti-metabolic and antineoplastic. It is researched and developed by the Eli Lilly and Company and approved to be listed in South Africa, Sweden, the Netherlands, Australia and other countries in 1995. The United States Food and Drug Administration ( referred FDA) approved it as the first-line therapy for the clinical treatment of non-small cell lung cancer and pancreatic cancer.
Application&Function
Gemcitabine hydrochloride is a 2'-deoxycytidine hydrochloriode having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine hydrochloride is used in the treatment of various carcinomas, including non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.
Specification



 
Product Tag:
Related categories:
Scroll to Top